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Abstract 
Background: We have identified a novel class 1 integron (1503 bp), named In671 in a clinical Pseudomonas aerugi-
nosa isolate. Integron sequence analysis revealed two gene cassettes, one coding for a new OXA-type β-lactamase 
designated as OXA-205 and the other coding for the aadB gene that is responsible for aminoglycoside resistance. The 
266 amino acid sequence of OXA-205 revealed that this β-lactamase belongs to the Ambler class D showing highest 
sequence homology to the OXA-2 sub-lineage. Our objective was to purify and characterize β-lactamase OXA-205.
Methods: Escherichia coli cells were transformed with a plasmid containing cloned blaOXA-205 gene from P. aerugi-
nosa. Purification of overproduced OXA-205 consisted of a single ion-exchange chromatography step. SDS-PAGE and 
isoelectric focusing were performed to determine the molecular mass and pI, respectively. Size-exclusion chromatog-
raphy was undertaken to determine the OXA-205 oligomerization state. Substrate hydrolysis reactions were employed 
to assess enzyme kinetic parameters.
Results: Purification of OXA-205 yielded the enzyme with >95 % purity (as verified by SDS-PAGE). Approximate yield 
of the protein was estimated to be 20 mg per liter of culture. OXA-205 had a pI at 8.1, molecular mass of 26 kDa and a 
monomeric native structure. Kinetic analysis revealed that OXA-205 hydrolyzed narrow spectrum substrates, including 
ampicillin, carbenicillin, oxacillin, penicillin G, cefazolin and cefuroxime. Additionally, we observed a substrate inhibi-
tion profile towards carbenicillin and oxacillin, but not with ampicillin or penicillin G. Our results also show that OXA-
205 conferred unusually high (among class D β-lactamases) resistance towards inhibition by NaCl.
Conclusions: OXA-205 can be considered a narrow spectrum monomeric β-lactamase that demonstrates unusually 
high resistance profile towards inhibition by NaCl.
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Background
β-Lactamases are enzymes that are capable of degrad-
ing β-lactam antibiotics via hydrolysis of the amide bond 
in their β-lactam ring [1]. Today, these enzymes are of 
great concern for being directly or indirectly respon-
sible for most of the multi-drug resistance observed in 
gram-negative bacteria in both hospital and community 
isolates [1, 2].
OXA-type β-lactamases are distinguished by their abil-
ity to hydrolyze cloxacillin or oxacillin at a 50  % higher 
rate than that of penicillin G and are inhibited by NaCl 
[3]. According to the functional classification, OXA-type 
enzymes are classified in group 2d which is further subdi-
vided into 2 subgroups: 2de (enzymes that are unable to 
hydrolyze carbapenems) and 2df (enzymes with carbap-
enem-hydrolyzing activities) [3]. Structural classification 
of β-lactamases according to the Ambler assigns OXA 
enzymes to the D class, which includes a great number 
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of diverse enzymes [4, 5]. However, it seems that all of 
them have a conserved carboxylated lysine residue in the 
active site [6]. Due to a great number of OXA variants 
and in some cases weak sequence similarity among these 
enzymes, data concerning their biochemical characteris-
tics are needed to fully understand them.
In this paper, we report biochemical characteristics, 
substrate hydrolysis and inhibition profiles of OXA-
type β-lactamase, designated as OXA-205 from a Pseu-




Pseudomonas aeruginosa P16 was recovered from an eye 
infection of a hospitalized patient in Lithuanian Univer-
sity of Health Sciences Kauno Klinikos Hospital. Species 
identification of P. aeruginosa P16 isolate was performed 
with the automated microbiology system Phoenix™ 
(BD) and confirmed by PCR using primers PA-SS-F 
(5′-GGGGGATCTTCGGACCTCA-3′) and PA-SS-R 
(5′-TCCTTAGAGTGCCCACCCG-3′) [7] and reference 
strain P. aeruginosa ATCC 27853. For plasmid transfer, 
OXA-205 cloning and expression, E. coli strains JM107 
(used as the primary host for recombinant plasmids), 
DH5α and BL21 (DE3) were used.
Antimicrobial susceptibility testing
Antibiotic susceptibility for P. aeruginosa P16, E. coli 
DH5α harboring an empty vector and vector expressing 
OXA-205 was determined in Mueller–Hinton broth (Lio-
filchem), using a final inoculum of 5 × 105 CFU/ml. Anti-
biotics were obtained from Trek. Testing was performed 
by the broth microdilution method, as described in the 
Clinical and Laboratory Standards Institute guidelines 
[8].
Genetic manipulations
The molecular biology tools were purchased from 
Thermo Fisher Scientific Baltics and used as recom-
mended by the manufacturer. Primers were pur-
chased from Metabion. To clone 801 bp  blaOXA-205 
gene, the DNA was amplified using primers 205clF6 
(5′-GTTGGAATTCATTAAAGAGGAGAAATTAAG 
CATGGCAATCCGATTCCTCACC-3′) and 205clR3 
(5′-GCCCGGATCCAAGCAGACTTGACCTGA-3′). 
The former contained fragment of the vector sequence 
upstream from the specific part to the beginning of 
blaOXA-205 so that the insert would be cloned in frame. 
The latter was specific to the 3′ conserved segment of 
class 1 integrons [9]. For cloning purposes, EcoRI and 
BamHI restriction sites were introduced into the prim-
ers (underlined), respectively. The obtained fragment was 
digested with EcoRI and BamHI and inserted between 
the EcoRI and BamHI sites of pUHE 25-2(cat) plasmid 
[10], resulting in plasmid pUHEcat-OXA-205 which 
was introduced into E. coli DH5α. For the purification of 
OXA-205, the gene without signal peptide coding region 
was amplified with primers 205clF5 (5′-GTTGTCTAG 
AAATAATTTTGTTTAACTTTAAGAAGGAGAT 
ATACCATGCAAGAACACGTGGTAGTCCG-3′), con-
taining XbaI restriction site (underlined) and 205clR2 
(5′-GCCCGAATTCAAGCAGACTTGACCTGA-3′). 
The latter was identical to the primer 205clR3, except it 
had EcoRI restriction site. The amplified fragment was 
digested with XbaI and EcoRI and inserted between the 
XbaI and EcoRI sites of pET-28b, resulting in plasmid 
pET-OXA-205 which was introduced into E. coli BL21 
(DE3). P. aeruginosa P16 genomic DNA was used as the 
template. pUHEcat-OXA-205 and pET-OXA-205 trans-
formants were selected on chloramphenicol (33  μg/
ml) or kanamycin (60 μg/ml) containing LB agar plates, 
respectively. The accuracy of the cloned DNA inserts was 
verified by confirmatory sequencing (Macrogen).
Production and purification of OXA‑205
E. coli BL21(DE3) cells containing pET-OXA-205 plas-
mid were grown overnight at 37  °C in LB medium con-
taining kanamycin (60 µg/ml). Culture was diluted 1:100 
with fresh LB medium, containing kanamycin (60 µg/ml), 
grown at 28 °C to an A600 = 0.6 and induced with IPTG 
(Thermo Fisher Scientific Baltics) (final concentration 
of 1  mM) for 18  h. After induction the cells were har-
vested by centrifugation at 6000 ×  g for 15 min at 4  °C, 
resuspended in 50  mM Tris-H2SO4 (pH 7.4) buffer and 
disrupted by sonication. Debris was eliminated by cen-
trifugation at 12000 ×  g for 30  min at 4  °C. The extract 
was filtered through a 0.22 µm membrane filter and then 
loaded at 2  ml/min on anion-exchange column HiLoad 
16/10 Q Sepharose HP (GE Healthcare), previously equili-
brated with 50  mM Tris-H2SO4 (pH 7.4).The purified 
OXA-205 was eluted in the flow-through fraction. HiTrap 
Desalting column (GE Healthcare) was used for buffer 
exchange using a 100 mM sodium phosphate buffer (pH 
7.0) as an eluent. The fractions of the purified enzyme 
were stored at −80  °C. All chromatography steps were 
performed using ÄKTA FPLC system (GE Healthcare).
Protein analysis
The purity of each chromatography step was deter-
mined by SDS-PAGE. Protein concentration was 
assayed by Bradford method using Roti–Quant kit 
(Roth) with bovine serum albumin (BSA) as a standard. 
The oligomerization state of OXA-205 was determined 
as described previously [11], except the Superose 12 
10/300 GL column, flow rate of 0.5  ml/min and 60  µg 
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of the purified protein were used. The column was cali-
brated with a mixture containing BSA (67  kDa), oval-
bumin (43  kDa), chymotrypsinogen A (25  kDa), and 
RNaseA (13.7 kDa) (GE Healthcare) using the same flow 
rate conditions as mentioned above. Isoelectric focusing 
(IEF) was performed with IPG gel strips (pH 3–10) with 
Multiphor II device (GE Healthcare) according to the 
manufacturer’s protocol. After focusing, β-lactamase 
bands were detected by overlaying the strips with 
0.5  mM nitrocefin. The pI values were determined 
and compared to those from molecular IEF standards 
(Bio-Rad).
Determination of kinetic parameters
All kinetic measurements were performed at room tem-
perature in 100  mM sodium phosphate buffer (pH 7.0) 
supplemented with 50  mM NaHCO3 and 0.2  mg/ml 
BSA in a total volume of 500  μl, unless specified other-
wise. The variations in absorbance were measured using 
Genesys 10S UV–vis spectrophotometer (Thermo Sci-
entific). The wavelengths and changes in extinction 
coefficients used in the spectrophotometric assays were 
ε486  =  20,500  M−1  cm−1 with nitrocefin (Calbiochem). 
For carbapenems and other substrates, parameters were 
as in [12, 11, 13], respectively. The values of kinetic 
parameters (Km and kcat) were determined by measuring 
the initial rate (v) of hydrolysis of various different con-
centrations of β-lactams and fitting the data with non-
linear regression to the Michaelis–Menten equation. 
Km values lower than 20 μM were determined as Ki in a 
competition experiments with 0.1  mM nitrocefin as the 
reporter substrate [14].
For substrates that at high concentrations demon-
strated substrate inhibition, data was fitted using kinetic 
model (Eq. 1) described by LiCata and Allewell [15].
where Vmax and Vi correspond to the catalytic constants 
kcat and kcat(i), respectively. K is the Michaelis constant, Ki 
is the inhibition constant, [S] is the substrate concentra-
tion, v is the initial velocity. Exponents nH and x are the 
Hill’s coefficients allowing for cooperativity of substrate 
hydrolysis and inhibition modes, respectively. In the case 
of complete inhibition (Vi = 0), the Eq. 1 reduces to the 
Eq. 2.
The inhibitory concentration of NaCl that reduced the 
hydrolysis rate of substrate by 50  % (IC50) was assayed 








































under conditions in which OXA-205 was preincubated 
with various concentrations of salt for 3 min before the 
addition of the substrate.
All data fitting in this work was performed using the 
open source QtiPlot software [16]. Specific activity of 
OXA-205 was defined as the amount (unit of enzyme) 
that hydrolyzed 1 µmol of nitrocefin/minute/milligram of 
protein.
Bioinformatic analysis
NCBI BLASTP was used to determine sequence simi-
larities. Multiple amino acid sequence alignments were 
generated with the Cobalt alignment tool [17]. Sequence 
alignments and secondary structure information using 
OXA-46 structure as the reference (PDB:3IF6) were ren-
dered using ESPript online server [18]. Theoretical calcu-
lation of protein molecular mass and pI was carried out 
using the software available at the ExPASy proteomic 
server (http://www.expasy.org/). Theoretical predic-
tion of the leader peptide size was carried out at with 
the SignalP 3.0 [19]. OXA-205 model based on OXA-46 
structure (PDB:3IF6) was created using SWISS-MODEL 
online tool [20, 21].
Results and discussion
Characterization of integron‑encoded OXA‑type 
β‑lactamase from the P. aeruginosa P16 isolate
During the search for class 1and 2 integrons of a total 
of 111 MDR P. aeruginosa isolates, obtained from vari-
ous clinical specimens collected in six regional hospitals 
in Lithuania during the period of 2005–2007, a novel 
class 1 integron (1503  bp), named In671 was identified 
in multidrug-resistant P. aeruginosa isolate P16, recov-
ered from an eye infection of a patient of Lithuanian Uni-
versity of Health Sciences Kauno Klinikos Hospital [22]. 
Antimicrobial susceptibility testing showed that the iso-
late was resistant to almost all antibiotics that were tested 
(Table 1).
Analysis of the novel 1503 bp gene cassette array of the 
integron revealed two gene cassettes, one coding aadB 
gene that is responsible for aminoglycoside resistance 
and the other coding for a new OXA-type β-lactamase, 
which was designated as OXA-205 (Fig.  1). Within the 
deduced 266 amino acid sequence all the conserved 
motifs typical for class D enzymes were found, namely, 
70STFK73 [23], 118SXV120 [23], 144YGN146 [23], 
164  W [24], 216KTG218 [23], 68P [4], 131G [4], 171I 
[4], 188L [4], 232 W [4], 235G [4], 247F [4] (residues are 
numbered according to class D β-lactamase (DBL) num-
bering scheme [25]) (Fig. 2). Fully matured protein (after 
the removal of the predicted 21  N-terminal amino acid 
signal peptide) is predicted to have a molecular weight 
(Mw) of 28,455 Da.
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Comparison of amino acid sequence of OXA-205 with 
other class D β-lactamases revealed that it belonged 
to the OXA-2 sub-lineage [11] showing the highest 
sequence similarity to two OXA-type enzymes: OXA-
118 and OXA-119, which were also found in integrons. 
The first one was found in uncultured bacteria from a 
wastewater plant and the other in a clinical Burkholderia 
cepacia isolate (97 and 96  % sequence identity, respec-
tively) [11, 22]. OXA-205 exhibited 92 % sequence iden-
tity with the well-characterized narrow spectrum class 
D β-lactamase OXA-46 [11]. The remaining OXA-2 
sub-linage enzymes (OXA-2, OXA-3, OXA-20, OXA-
53) showed 80  % sequence similarities to OXA-205. 
Although P. aeruginosa isolate P16 was resistant to imi-
penem, OXA-205 sequence shared a weak similarity with 
carbapenem-hydrolyzing class D β-lactamases (<40  % 
sequence identity with OXA-23 group, OXA-48 and 
OXA-58 group enzymes).
Antimicrobial susceptibility testing
E. coli DH5α strain was transformed with the plasmid 
pUHEcat-OXA-205 and compared against E. coli con-
taining empty the vector pUHE 25-2(cat) in terms of sus-
ceptibility to various of β-lactams (Table 1).
The former strain demonstrated increased resistance 
to penicillins (ampicillin, penicillin G, piperacillin and 
carbenicillin), cefazolin and cefotetan. Interestingly, 
the OXA-205 expressing strain showed no significant 
increase in the resistance against oxacillin, even though 
this β-lactam was efficiently hydrolyzed by the puri-
fied enzyme (see below). Susceptibility of E. coli DH5α 
(pUHEcat-OXA-205) to aztreonam, cephalosporins 
(cefuroxime, cefoxitin, ceftazidime, ceftriaxone, cefotax-
ime, cefpodoxime and cefepime) and carbapenems (imi-
penem and meropenem) were unaffected. The obtained 
MIC results data allow for the conclusion that OXA-
205, when expressed in E. coli DH5α, confers resistance 
against narrow spectrum β-lactams.
Expression and biochemical properties of OXA‑205
After over-expression and purification, we obtained 
approximately 20 mg of OXA-205 per liter of culture, 
Table 1 MIC of E. coli DH5α (pUHEcat-OXA-205) in comparison with E. coli DH5α (pUHE 25-2(cat)) and P. aeruginosa P16
Antimicrobial MIC (μg/ml) for






Ampicillin 512 1 512
Aztreonam 4 0.06 0.06
Cefazolin >2048 2 16
Cefepime 2 0.02 0.03
Cefotetan >32 0.13 4
Ceftriaxone 16 0.06 0.03
Ceftazidime 2 0.06 0.06
Cefoxitin >64 8 8
Cefuroxime 1024 2 2
Penicillin G 2048 16 1024
Imipenem 16 0.25 0.5
Meropenem 8 0.03 0.06
Piperacillin 8 0.5 32
Cefpodoxime >32 0.5 0.5
Carbenicillin 256 4 2048
Oxacillin 2048 128 256
Cefotaxime 16 0.03 0.03
Fig. 1 Structure of 1503 bp gene cassette array of In671 integron 
[GenBank:JF800667.1]. Gene cassettes are represented by flat empty 
arrows; putative elements are represented by filled boxes. The 5′-CS 
and 3′-CS show the orientation of the integron. The thin arrows point-
ing downwards show recombination sites attI, attCaadb, and attCOXA-205, 
respectively. Numbers mark the sequenced length of the integron 
and the position of each of the genes
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with the specific activity of  ~60 U/mg (measured 
against nitrocefin). SDS-PAGE revealed that the puri-
fied enzyme was  >95  % homogeneous (Additional 
file  1: Figure S1). The produced β-lactamase had a pI 
of 8.1 and molecular weight of  ~26  kDa (as judged 
from SDS-PAGE analysis using Fiji open source soft-
ware [26]).
In order to determine the oligomerization state of 
OXA-205, size exclusion chromatography was under-
taken. The approximate molecular mass was estimated 
to be 25  kDa, suggesting a monomeric native form of 
OXA-205. This result was quite unexpected, because 
dimerization had been observed among some of the D 
class β-lactamases, including OXA-10 [23]; OXA-13 [27]; 
Fig. 2 Amino acid sequence comparison of OXA-205 with the representatives of the OXA-2 lineage. Sequences of OXA-46 [GenBank:AAN63499.1] 
OXA-2 [GenBank:CAC82805.1]; OXA-3 [GenBank:AAC41449.1]; OXA-20 [GenBank:CAA30246.1]; OXA-53 [GenBank:AAP43641.1]; Bce (OXA-119), 
an OXA-type enzyme from Burkholderia cepacia clinical isolate from Ireland [GenBank:AAK55330.1]; OXA-PMW (OXA-118), an OXA-type enzyme 
encoded by a plasmid from an unidentified bacterium from a wastewater treatment plant in Germany [GenBank:AAN41427.1) are shown. The struc-
tural elements of chain C of OXA-46 enzyme (PDB:3IF6) are shown above the sequence: α, α-helices; β, β-strands; η, 3/10-helix. Predicted 21-amino 
acid N-terminal signal peptide is marked by black rectangles below the alignment. Identical residues are shaded in black. Black bald characters mark 
similar residues. Typical conserved motifs of class D enzymes are marked by the asterisk below the alignment [4]. Residues that are predicted to be 
involved in the dimerisation are shown by triangles. Residues are numbered according to class D β-lactamase (DBL) numbering [25]
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OXA-29 [28] and, most importantly, among the three 
representatives of OXA-2 sub-lineage [11], namely OXA-
46 [11, 29]; OXA-3 [30] and OXA-2 itself [30].
It is known that at least two enzymes, OXA-29 and 
OXA-46, form dimers independently of divalent cati-
ons [11, 28, 29]. The solved quaternary structure of the 
OXA-46 revealed several amino acid residues impor-
tant for the cation-independent inter-subunit interac-
tions. These include (according to DBL numbering): β7 
strand; Glu89, Asn186, Arg197, Asp201, Arg214 [29], 
and Glu238 [23]. Interestingly, after a close inspection of 
OXA-205 sequence we noticed Asp201 substitution by 
Tyr201. It has been proposed that Asp201 and Arg214 
might form a salt bridge which could replace the cation 
site leading to a dimeric cation-independent structure 
[23, 31]. We speculate that this could be one of the main 
reasons why OXA-205 did not dimerize. Indeed, the 
model of OXA-205 based on the OXA-46 protein qua-
ternary structure showed lack of interactions between 
the Tyr201and the Arg214 of OXA-205 (Fig.  3). How-
ever, site-directed mutagenesis is needed to fully support 
this hypothesis.
Kinetic parameters of OXA‑205
As expected, OXA-205 efficiently hydrolyzed penicillins 
and 1st generation of cephalosporins, including ampicil-
lin, carbenicillin, oxacillin, penicillin G and cefazolin 
(Table 2). Penicillin G was the best substrate that showed 
the highest catalytic efficiency (kcat/Km) with the value of 
1.68 × 107 M−1 s−1. Efficiency values for other substrates 
were similar to those reported for OXA-46 [11]. Interest-
ingly, at high concentrations of carbenicillin and oxacillin 
(starting at approximately 2  mM and 1.6  mM for car-
benicillin and oxacillin, respectively) we observed sub-
strate inhibition kinetics. In order to measure values of 
constants accurately, we fitted data to the Eq. 2 because 
the inhibition profile demonstrated complete inhibition 
(Additional file 2: Figure S2). As already mentioned, the 
calculated efficiency values were similar to the already 
reported ones for OXA-46, however OXA-205 efficiency 
towards oxacillin, compared to OXA-2, was more than 
one order of magnitude lower [12]. Also, we obtained 
Hills coefficients (n = 2.1 ± 0.2 and x = 4.9 ± 0.7 for car-
benicillin and n = 1.1 ± 0.2 and x = 3.6 ± 0.7 for oxa-
cillin) which indicated cooperative effects in both the 
hydrolysis and inhibition by carbenicillin, while only 
inhibition by oxacillin demonstrated cooperative manner. 
To the best of our knowledge, substrate inhibition is not 
unique among β-lactamases, however it seems that it is 
the first example among non-metallo-β-lactamases [32, 
33]. Currently, the exact mechanism of substrate inhibi-
tion for β-lactamases is unknown but it was suggested 
that it might be linked to the bulky aromatic ring substi-
tutions in some of the antibiotics and the peculiarities of 
the active sites of β-lactamases [33].
Also, we observed that OXA-205 influenced hydrol-
ysis of the 2nd generation cefalosporin cefuroxime. 
However, a very low turnover number (kcat) and rather 
high affinity (Km) resulted in poor hydrolysis efficiency 
(6.69 ×  102  M−1  s−1). Lastly, we did not observe any of 
OXA-205 influenced hydrolysis of ceftazidime (the 3rd 
generation cefalosporin), suggesting that OXA-205 could 
be considered a narrow spectrum β-lactamase towards 
cefalosporins.
Fig. 3 Molecular model of OXA-205 based on OXA-46 quaternary structure. D201, R210 and E238 residues forms H-bonds between different 
subunits in OXA-46 while D201Y substitution in OXA-205 model fails to make H-bonds with R214 residue in different subunit. Substitution also 
introduces clashes (data not shown). Blue and purple colors of cartoon ribbons denotes different subunits. Aforementioned residues (along with 
E89, N186, R197 and β7 strand strand in C-terminal end) are thought to be responsible for the formation of dimeric structure in divalent metal ions 
independent way [23, 29]. GMQE and QMEAN4 values of the model are 0.71 and −2.13, respectively. Model was created using SWISS-MODEL tool 
[20, 21] (OXA-46 assembly No. 2 from Protein data bank in Europe (PDB:3IF6) was used as a template) and visualized with the open source software 
PyMol (v.1.7.1.2)
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It has been shown that OXA-2 displays similar cata-
lytic efficiencies towards carbapenems as some of the 
recognized class D carbapenemases [13]. Strikingly, our 
data supported this observation—OXA-205 hydrolyzed 
imipenem and meropenem as efficient as ampicillin and 
oxacillin, respectively. However, OXA-205 displayed very 
low turnover numbers, which were approximately one 
order of magnitude lower when compared to OXA-2. 
Nevertheless, the enzyme demonstrated a high affinity 
towards carbapenems. This data support the suggestion 
that other class D enzymes which currently are regarded 
as non-carbapenemases may, in fact be carbapenem-
hydrolysing class D β-lactamases [12].
Inhibition by sodium chloride (NaCl) is considered 
one of the useful characteristics for in  vitro identifica-
tion of class D β-lactamases: most enzymes are fully 
inactivated with ≥100 mM NaCl [34]. In order to deter-
mine the pattern of susceptibility to NaCl, we performed 
inhibition experiments which concluded that OXA-
205 was inhibited by salt at extremely high concentra-
tion—IC50  =  1361  ±  118  mM. Interestingly, OXA-46 
also demonstrated reduced susceptibility to NaCl (IC50 
at ~230 mM) [11]. These results suggest that low resist-
ance to NaCl may be widespread among the enzymes 
belonging to the OXA-2 sub-lineage.
Conclusion
Our study characterized a new OXA-type β-lactamase 
OXA-205 which displayed a monomeric oligomeriza-
tion state which we speculated could at least partially 
was influenced by a single amino acid substitution. Our 
results also showed that even though OXA-205 dem-
onstrated narrow spectrum hydrolysis profile towards 
penicillins and cephalosporins it also readily hydrolyzed 
carbapenems and conferred unusually high resistance 
towards inhibition by NaCl. Interestingly, carbenicillin 
and oxacillin, but not other penicillins demonstrated a 
substrate inhibition profile which could be considered as 
a novel feature among class D β-lactamases. All in all, our 
work further expands knowledge regarding molecular 
and biochemical heterogeneity of β-lactamases.
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Additional files
Additional file 1: Figure S1. SDS-polyacrylamide gel of OXA-205 puri-
fication. Lanes: 1 – cell fraction of E. coli BL21 (DE3) (pET-OXA-205) before 
induction with 1 mM IPTG; 2–Thermo Scientific PageRuler Prestained 
Protein ladder (SM0671); 3 – cell fraction of E. coli BL21 (DE3) (pET-
OXA-205) after induction with 1 mM IPTG; 4 – purified cell fraction after 
anion-exchange, using 10 μg of total protein; 5 – purified cell fraction after 
anion-exchange, using 20 μg of total protein; 6 – purified cell fraction after 
anion-exchange, using 30 μg of total protein; 7–purified cell fraction after 
anion-exchange, using 40 μg of total protein. Relative migrations of Mw 
marker proteins are indicated on the left.
Additional file 2: Figure S2. Inhibition of OXA-205 by carbenicillin and 
oxacillin. The data (filled square) is plotted as initial velocity (v) versus 
substrate concentration for oxacillin (upper plot) and carbenicillin (lower 
plot). Error bars represent standard deviation from three different meas-
ures. The solid line in each plot is a fit to the data using Eq. 2 using kinetic 
parameters form Table 2.
Table 2 Kinetic parameters determined with the purified OXA-205 β-lactamase
Reactions were carried out using the concentration of OXA-205 ranging from 2.5 to 814 nM. All values are the means of at least three different measurements
NH no hydrolysis observed at a substrate concentration up to 1 mM
– Not calculated
a Measured as an inhibition constant (Ki) in competition experiment against nitrocefin [13]
b Obtained data was fitted to the Eq. 2 because substrate inhibition kinetics were observed
Substrate Km (μM) kcat (s
−1) kcat/Km (M
−1 s−1) Ki (μM) n x
Nitrocefin 6.9 ± 0.4 62.4 ± 3.3 9.09 × 106
Ampicillin 18.1 ± 0.6 36.4 ± 0.1 2.01 × 106
Carbenicillinb 360 ± 21 45.2 ± 1.9 1.26 × 105 2887 ± 56 2.1 ± 0.2 4.9 ± 0.7
Cefazolin 4.7 ± 0.3a 3.9 ± 0.1 8.25 × 105
Ceftazidime NH NH –
Cefuroxime 30.4 ± 2.5 0.02 ± 0.001 6.69 × 102
Imipenem 0.02 ± 0.002a 0.03 ± 0.001 1.39 × 106
Meropenem 0.02 ± 0.002a 0.008 ± 0.0005 3.08 × 105
Oxacillinb 1369 ± 87 376 ± 25 2.75 × 105 1869 ± 75 1.1 ± 0.1 3.6 ± 0.2
Penicillin G 2.3 ± 0.06a 39.1 ± 2 1.68 × 107
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